• Relay Therapeutics amended its at-the-market common stock sales agreement with TD Securities, raising the maximum offering size to $462.98 million from $250 million.
• The amendment also updates the permitted sale methods to include negotiated transactions such as block trades.
• A prospectus supplement reflecting the amendment is slated to be filed within two business days.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Relay Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-338013), on August 06, 2026, and is solely responsible for the information contained therein.